JP2009507015A5 - - Google Patents

Download PDF

Info

Publication number
JP2009507015A5
JP2009507015A5 JP2008529047A JP2008529047A JP2009507015A5 JP 2009507015 A5 JP2009507015 A5 JP 2009507015A5 JP 2008529047 A JP2008529047 A JP 2008529047A JP 2008529047 A JP2008529047 A JP 2008529047A JP 2009507015 A5 JP2009507015 A5 JP 2009507015A5
Authority
JP
Japan
Prior art keywords
salt
euglobulin
blood
generating
depleted intermediate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008529047A
Other languages
English (en)
Japanese (ja)
Other versions
JP5178518B2 (ja
JP2009507015A (ja
Filing date
Publication date
Priority claimed from US11/217,956 external-priority patent/US20070049732A1/en
Application filed filed Critical
Priority claimed from PCT/US2006/030465 external-priority patent/WO2007030244A2/en
Publication of JP2009507015A publication Critical patent/JP2009507015A/ja
Publication of JP2009507015A5 publication Critical patent/JP2009507015A5/ja
Application granted granted Critical
Publication of JP5178518B2 publication Critical patent/JP5178518B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008529047A 2005-09-01 2006-08-04 超高収率静注免疫グロブリン製剤 Active JP5178518B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11/217,956 2005-09-01
US11/217,956 US20070049732A1 (en) 2005-09-01 2005-09-01 Ultra-high yield intravenous immune globulin preparation
US11/232,527 2005-09-22
US11/232,527 US7879331B2 (en) 2005-09-01 2005-09-22 Ultra-high yield intravenous immune globulin preparation
PCT/US2006/030465 WO2007030244A2 (en) 2005-09-01 2006-08-04 An ultra-high yield intravenous immune globulin preparation

Publications (3)

Publication Number Publication Date
JP2009507015A JP2009507015A (ja) 2009-02-19
JP2009507015A5 true JP2009507015A5 (enExample) 2012-12-13
JP5178518B2 JP5178518B2 (ja) 2013-04-10

Family

ID=37805216

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008529047A Active JP5178518B2 (ja) 2005-09-01 2006-08-04 超高収率静注免疫グロブリン製剤

Country Status (6)

Country Link
US (3) US20070049732A1 (enExample)
JP (1) JP5178518B2 (enExample)
CN (1) CN101528776B (enExample)
AT (1) ATE541858T1 (enExample)
CA (1) CA2621025C (enExample)
ES (1) ES2384930T3 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1909831A4 (en) 2005-06-14 2013-02-20 Amgen Inc SELF-BUFFING PROTEIN FORMULATIONS
WO2009129226A1 (en) 2008-04-15 2009-10-22 Talecris Biotherapeutics, Inc. Two-stage ultrafiltration/diafiltration
WO2010148117A1 (en) 2009-06-17 2010-12-23 Scantibodies Laboratory, Inc. Therapeutic and diagnostic affinity purified specific polyclonal antibodies
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
AU2012284122B2 (en) 2011-07-18 2017-06-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for inhibiting polyomavirus-associated pathology
US9696305B2 (en) 2011-10-31 2017-07-04 Bloodworks Antibody response phenotyping
CN102949719A (zh) * 2012-04-28 2013-03-06 上海市徐汇区中心医院 静脉注射免疫球蛋白抑制霍乱毒素和半乳糖凝集素-1结合到神经节苷脂gm1
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
US9556253B2 (en) 2014-12-02 2017-01-31 Hemarus Therapeutics Limited Process for increased yield of immunoglobulin from human plasma
WO2017066683A1 (en) 2015-10-15 2017-04-20 Plasma Technologies, Llc Methods for extracting proteins from blood plasma
CA3012694A1 (en) 2016-02-03 2017-08-10 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
AU2017345490B2 (en) 2016-10-21 2022-07-07 Amgen Inc. Pharmaceutical formulations and methods of making the same
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN108008060B (zh) * 2017-09-21 2020-07-28 中国农业科学院农业质量标准与检测技术研究所 一种饲料中羟脯氨酸的测定方法及试剂
US10815270B1 (en) 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation
KR20220079572A (ko) * 2019-09-20 2022-06-13 플라즈마 테크놀로지스, 엘엘씨 치료 단백질 조성물 및 방법(therapeutic protein compositions and methods)
EP4271706A4 (en) * 2020-12-28 2025-01-15 Plasma Technologies LLC SYSTEMS AND METHODS FOR THE ISOLATION OF IMMUNGLOBULIN G ON A PROCESS SCALE
CN115369104B (zh) * 2022-09-27 2023-09-08 四川新川义生物科技有限责任公司 一种精制胃蛋白酶的方法
WO2025085544A1 (en) * 2023-10-17 2025-04-24 Plasma Technologies, Llc Integrated process for isolation of plasma proteins

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US4067863A (en) * 1969-03-28 1978-01-10 Watt John G Blood plasma fractionation
CA1064396A (en) * 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
JPS5234918A (en) * 1975-09-06 1977-03-17 Biotest Serum Institut Gmbh Production of gmmaglobulin suitable for dosing into vein
US4126605A (en) * 1975-12-29 1978-11-21 Plasmesco Ag Process of improving the compatibility of gamma globulins
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
US4296027A (en) * 1977-08-31 1981-10-20 The Regents Of The University Of Minnesota Pure intravenous human and animal gamma globulins
NL7815052A (nl) * 1977-11-17 1980-01-31 Procter & Gamble Korrelvormige wasmiddelen ter betere verwijdering van vet vuil.
US4163370A (en) * 1977-11-21 1979-08-07 Corning Glass Works Controlling the drawing rollers to produce diameter perturbations in an optical waveguide
DE2835843A1 (de) * 1978-08-16 1980-02-28 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung
DE2837168A1 (de) * 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
US4246085A (en) * 1979-02-16 1981-01-20 United Kingdom Atomic Energy Authority Fractionation of proteins
JPS5681521A (en) 1979-12-10 1981-07-03 Toyo Soda Mfg Co Ltd Separation of blood serum and protein
US4321192A (en) * 1980-01-10 1982-03-23 Ionics Incorporated Fractionation of protein mixtures by salt addition followed by dialysis treatment
JPS5855432A (ja) * 1981-09-29 1983-04-01 Fujirebio Inc 静脈注射用免疫グロブリンの製法
US4371520A (en) * 1981-10-28 1983-02-01 The Green Cross Corporation Process for preparing immunoglobulin suitable for intravenous injection
US4624780A (en) * 1982-06-28 1986-11-25 Alpha Therapeutic Corporation Fractionation of blood plasma
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4486282A (en) * 1983-02-22 1984-12-04 University Patents, Inc. Precipitation of proteins from salt-containing proteinaceous fluids employing a desalting treatment, and use thereof in selective plasmapheresis
JPS59157017A (ja) * 1983-02-25 1984-09-06 Green Cross Corp:The 静脈投与用γ−グロブリン製剤
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4835257A (en) * 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
US5310877A (en) * 1993-04-08 1994-05-10 E. I. Du Pont De Nemours And Company Method for separating serum albumin and gamma globulin
US5429746A (en) * 1994-02-22 1995-07-04 Smith Kline Beecham Corporation Antibody purification
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
TW491855B (en) * 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
GB9705810D0 (en) * 1997-03-20 1997-05-07 Common Services Agency Intravenous immune globulin
AT407159B (de) * 1997-06-13 2001-01-25 Immuno Ag Verfahren zur abreicherung von viralen und molekularen pathogenen aus einem biologischen material
US5886154A (en) * 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
ES2421736T3 (es) * 1998-06-09 2013-09-05 Csl Behring Ag Procedimiento para la preparación de inmunoglobulinas para administración intravenosa y otros productos inmunoglobulínicos
AUPP971399A0 (en) * 1999-04-12 1999-05-06 Life Therapeutics Limited Separation of plasma components
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
AU2002248415B8 (en) * 2001-02-07 2008-07-24 Shanbrom Technologies , Llc Carboxylic Acid Such as Citric Acid for Disinfecting or Enhacing the Production of Blood Products Such as Plasma, Cryoprecipitate and/or Platelet
US6806355B2 (en) * 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
US6893639B2 (en) * 2001-10-19 2005-05-17 Hemacare Corporation Method for high yield purification of immune globulins from blood plasma and blood plasma intermediates
US6881573B2 (en) * 2003-09-12 2005-04-19 Allan L. Louderback Augmented solvent/detergent method for inactivating enveloped and non-enveloped viruses

Similar Documents

Publication Publication Date Title
JP2009507015A5 (enExample)
JP6039828B2 (ja) モノクローナル抗体の精製方法
CN108779144B (zh) 从血液原料中提取蛋白质的方法
JP5704918B2 (ja) 第ｖｉｉｉ因子およびフォンビルブラント因子の精製方法
US11719690B2 (en) Methods for extracting A1P1 and albumin from blood plasma
JP2013528183A5 (enExample)
JP3771935B2 (ja) 水溶性血漿タンパク質の純化方法
CA2621025C (en) An ultra-high yield intravenous immune globulin preparation
US20250340589A1 (en) Purifying antibodies
WO2008068455A1 (en) Protein purification
DK156764B (da) Fremgangsmaade til fremstilling af et faktor viii-(ahf)-hoejkoncentrat
FR2648048A1 (fr) Procede de preparation de solutions d'albumine purifiee
JP2001500867A (ja) 血漿タンパク質含有薬剤の製造方法
WO2006046626A1 (ja) 水溶性エラスチンとその製造方法及びそれを含む食品と医薬
FR2701263A1 (fr) Procédé d'obtention d'une composition aqueuse protéinique, composition correspondante, glycoprotéine contenue et son utilisation pour la stabilisation de l'albumine et la détection ou le dosage d'anticorps.
JP2008540462A (ja) 免疫グロブリン分画およびそのためのプロセス
CN104004091B (zh) 一种人免疫球蛋白的制备工艺
CN104804078B (zh) 人体血清凝血因子ⅷ中的病毒过滤方法
Madhusudhan et al. Aqueous Two-Phase Extraction in Downstream Processing
JP2006182649A (ja) アルブミン凝集体及び／または不純蛋白質の除去方法
JPH0150384B2 (enExample)
Bhiman Optimisation of ultrafiltration for human serum albumin at NBI
JPH04230700A (ja) 抗ヒトリンパ球抗体の製造方法
JPS5843372B2 (ja) ＩｇＡの精製法
JPS58121219A (ja) ヒト血液凝固第１０３因子の製造方法